Literature DB >> 21513811

The metabolic basis of Candida albicans morphogenesis and quorum sensing.

Ting-Li Han1, Richard D Cannon, Silas G Villas-Bôas.   

Abstract

Candida albicans is a polymorphic fungus that has the ability to rapidly switch between yeast and filamentous forms. The morphological transition appears to be a critical virulence factor of this fungus. Recent studies have elucidated the signal transduction pathways and quorum sensing molecules that affect the morphological transition of C. albicans. The metabolic mechanisms that recognize, and respond to, such signaling molecules and promote the morphological changes at a system level, however, remain unknown. Here we review the metabolic basis of C. albicans morphogenesis and we discuss the role of primary metabolic pathways and quorum sensing molecules in the morphogenetic process. We have reconstructed, in silico, the central carbon metabolism and sterol biosynthesis of C. albicans based on its genome sequence, highlighting the metabolic pathways associated with the dimorphic transition and virulence as well as pathways involved in the biosynthesis of important quorum sensing molecules.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21513811     DOI: 10.1016/j.fgb.2011.04.002

Source DB:  PubMed          Journal:  Fungal Genet Biol        ISSN: 1087-1845            Impact factor:   3.495


  44 in total

1.  Inhibition of Yeast-to-Hypha Transition and Virulence of Candida albicans by 2-Alkylaminoquinoline Derivatives.

Authors:  Lili Meng; He Zhao; Shuo Zhao; Xiuyun Sun; Min Zhang; Yinyue Deng
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

2.  Small-Molecule Morphogenesis Modulators Enhance the Ability of 14-Helical β-Peptides To Prevent Candida albicans Biofilm Formation.

Authors:  Angélica de L Rodríguez López; Myung-Ryul Lee; Nathan B Wang; Kaitlin K Dunn; Hiram Sanchez; Namrata Raman; David R Andes; David M Lynn; Sean P Palecek
Journal:  Antimicrob Agents Chemother       Date:  2019-08-23       Impact factor: 5.191

3.  The impact of farnesol in combination with fluconazole on Candida albicans biofilm: regulation of ERG20, ERG9, and ERG11 genes.

Authors:  Stanislava Dižová; Lucia Černáková; Helena Bujdáková
Journal:  Folia Microbiol (Praha)       Date:  2017-12-12       Impact factor: 2.099

4.  Yeast and Filaments Have Specialized, Independent Activities in a Zebrafish Model of Candida albicans Infection.

Authors:  Brittany G Seman; Jessica L Moore; Allison K Scherer; Bailey A Blair; Sony Manandhar; Joshua M Jones; Robert T Wheeler
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

5.  Host-pathogen interaction and signaling molecule secretion are modified in the dpp3 knockout mutant of Candida lusitaniae.

Authors:  Ayman Sabra; Jean-Jacques Bessoule; Vessela Atanasova-Penichon; Thierry Noël; Karine Dementhon
Journal:  Infect Immun       Date:  2013-11-04       Impact factor: 3.441

6.  In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.

Authors:  Aspasia Katragkou; Matthew McCarthy; Elizabeth L Alexander; Charalampos Antachopoulos; Joseph Meletiadis; Mary Ann Jabra-Rizk; Vidmantas Petraitis; Emmanuel Roilides; Thomas J Walsh
Journal:  J Antimicrob Chemother       Date:  2014-10-06       Impact factor: 5.790

7.  Transcriptome analysis of the dimorphic transition induced by pH change and lipid biosynthesis in Trichosporon cutaneum.

Authors:  Ya Wang; Li Juan Tang; Xuan Peng; Zhi Bin Zhang; Hui Lin Yang; Ri Ming Yan; Du Zhu
Journal:  J Ind Microbiol Biotechnol       Date:  2019-12-13       Impact factor: 3.346

Review 8.  The Role of Fatty Acid Metabolites in Vaginal Health and Disease: Application to Candidiasis.

Authors:  Silke Baldewijns; Mart Sillen; Ilse Palmans; Paul Vandecruys; Patrick Van Dijck; Liesbeth Demuyser
Journal:  Front Microbiol       Date:  2021-07-02       Impact factor: 5.640

9.  Purpurin suppresses Candida albicans biofilm formation and hyphal development.

Authors:  Paul Wai-Kei Tsang; H M H N Bandara; Wing-Ping Fong
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

10.  Toward repurposing ciclopirox as an antibiotic against drug-resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae.

Authors:  Kimberly M Carlson-Banning; Andrew Chou; Zhen Liu; Richard J Hamill; Yongcheng Song; Lynn Zechiedrich
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.